XML 25 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Total
Revision of Prior Period, Accounting Standards Update, Adjustment
Common Stock
Additional Paid-in Capital
(Accumulated Deficit) Retained Earnings
(Accumulated Deficit) Retained Earnings
Revision of Prior Period, Accounting Standards Update, Adjustment
Accumulated Other Comprehensive Loss
Treasury Stock
Common stock, shares, outstanding, beginning (in shares) at Dec. 31, 2018     17,644,000         7,341,000
Stockholders' equity balance, beginning of the period at Dec. 31, 2018 $ (202,273) $ (5,030) $ 250 $ 237,726 $ 10,414 $ (5,030) $ (60) $ (450,603)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income 53,033       53,033      
Other comprehensive loss 1           1  
Purchase of Company common stock (in shares)     543,000         (543,000)
Purchase of Company common stock (47,356)             $ (47,356)
Reissuance of treasury stock (in shares)     187,000         (187,000)
Reissuance of treasury stock 6,938   $ (1) (1,318)       $ 8,257
Net issuance of shares for stock plans (in shares)     (12,000)          
Repurchase of restricted shares for taxes (in shares)     (24,000)          
Repurchase of restricted shares for taxes (2,242)     (2,242)        
Stock-based compensation 5,894     5,894        
Dividends on common stock 24,090     495 24,585      
Common stock, shares, outstanding, ending (in shares) at Jun. 30, 2019     17,252,000         7,697,000
Stockholders' equity balance, ending of the period at Jun. 30, 2019 (215,125)   $ 249 240,555 33,832   (59) $ (489,702)
Common stock, shares, outstanding, beginning (in shares) at Dec. 31, 2018     17,644,000         7,341,000
Stockholders' equity balance, beginning of the period at Dec. 31, 2018 $ (202,273) (5,030) $ 250 237,726 10,414 (5,030) (60) $ (450,603)
Common stock, shares, outstanding, ending (in shares) at Dec. 31, 2019 16,521,921   16,522,000         8,404,000
Stockholders' equity balance, ending of the period at Dec. 31, 2019 $ (241,774) (497) $ 249 246,192 61,653 (497) (58) $ (549,810)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member              
Common stock, shares, outstanding, beginning (in shares) at Mar. 31, 2019     17,651,000         7,324,000
Stockholders' equity balance, beginning of the period at Mar. 31, 2019 $ (190,821)   $ 250 239,585 24,588   (61) $ (455,183)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income 21,390       21,390      
Other comprehensive loss 2           2  
Purchase of Company common stock (in shares)     392,000         (392,000)
Purchase of Company common stock (35,341)             $ (35,341)
Reissuance of treasury stock (in shares)     19,000         (19,000)
Reissuance of treasury stock 170   $ (1) (651)       $ 822
Net issuance of shares for stock plans (in shares)     (21,000)          
Repurchase of restricted shares for taxes (in shares)     (5,000)          
Repurchase of restricted shares for taxes (425)     (425)        
Stock-based compensation 1,787     1,787        
Dividends on common stock 11,887     259 12,146      
Common stock, shares, outstanding, ending (in shares) at Jun. 30, 2019     17,252,000         7,697,000
Stockholders' equity balance, ending of the period at Jun. 30, 2019 $ (215,125)   $ 249 240,555 33,832   (59) $ (489,702)
Common stock, shares, outstanding, beginning (in shares) at Dec. 31, 2019 16,521,921   16,522,000         8,404,000
Stockholders' equity balance, beginning of the period at Dec. 31, 2019 $ (241,774) $ (497) $ 249 246,192 61,653 $ (497) (58) $ (549,810)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income (112,451)       (112,451)      
Purchase of Company common stock (in shares)     460,000         (460,000)
Purchase of Company common stock $ (26,527)             $ (26,527)
Reissuance of treasury stock (in shares) (380,607)   381,000         (381,000)
Reissuance of treasury stock $ 20,523   $ 0 3,367       $ 17,156
Net issuance of shares for stock plans (in shares)     4,000          
Repurchase of restricted shares for taxes (in shares)     (29,000)          
Repurchase of restricted shares for taxes (2,129)     (2,129)        
Stock-based compensation 6,670     6,670        
Dividends on common stock 12,208     507 12,715      
Other $ (178)     (178)        
Common stock, shares, outstanding, ending (in shares) at Jun. 30, 2020 16,417,618   16,418,000         8,483,000
Stockholders' equity balance, ending of the period at Jun. 30, 2020 $ (368,571)   $ 249 254,429 (64,010)   (58) $ (559,181)
Common stock, shares, outstanding, beginning (in shares) at Mar. 31, 2020     16,421,000         8,496,000
Stockholders' equity balance, beginning of the period at Mar. 31, 2020 (236,377)   $ 249 252,443 70,769   (58) $ (559,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income (134,779)       (134,779)      
Reissuance of treasury stock (in shares)     14,000         (13,000)
Reissuance of treasury stock (1)   $ 0 (600)       $ 599
Net issuance of shares for stock plans (in shares)     (14,000)          
Repurchase of restricted shares for taxes (in shares)     (3,000)          
Repurchase of restricted shares for taxes (129)     (129)        
Stock-based compensation 2,632     2,632        
Dividends on common stock 261     261        
Other $ (178)     (178)        
Common stock, shares, outstanding, ending (in shares) at Jun. 30, 2020 16,417,618   16,418,000         8,483,000
Stockholders' equity balance, ending of the period at Jun. 30, 2020 $ (368,571)   $ 249 $ 254,429 $ (64,010)   $ (58) $ (559,181)